Prolonged impact of anti-cancer therapy on endothelial function and arterial stiffness in breast cancer patients

CONCLUSIONS: In patients with breast cancer, there is progression of endothelial dysfunction and arteriosclerosis up to 15 months following initiation of anthracycline-based chemotherapy. Trastuzumab has no additive effect on endothelial function or arterial stiffness.PMID:37455009 | DOI:10.1016/j.vph.2023.107195

Source: Vascular Pharmacology - July 16, 2023 Category: Drugs & Pharmacology Authors: Maria Anastasiou Evangelos Oikonomou Panagiotis Theofilis George Angelos Papamikroulis Maria Gazouli Konstantinos Kalogeras Stavroula Lygkoni Theodoros Pesiridis Athina Goliopoulou Alkistis Papatheodoridi Amanda Psyrri Flora Zagouri Gerasimos Siasos Dimit Source Type: research